Literature DB >> 17545731

Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study.

Il Han Choo1, Dong Young Lee, Jong Choul Youn, Jin Hyeong Jhoo, Ki Woong Kim, Dong Soo Lee, Jae Sung Lee, Jong Inn Woo.   

Abstract

The study aimed to explore topographic progression pattern of brain functional impairment according to clinical stage in Alzheimer disease (AD). One hundred and sixteen AD patients and 25 normal subjects underwent a [18F] fluorodeoxyglucose-positron emission tomography scan. Regional cerebral glucose metabolism was compared between severity groups based on the Clinical Dementia Rating through voxel-based analyses. As clinical severity progressed, hypometabolic areas gradually increased, involving initially posterior cingulate cortex, later temporoparietal, and finally frontal and some subcortical areas. The results indicate that progression patterns of hypometabolism in AD are close to that of typical neuropathology, but that they do not fully coincide with it.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545731     DOI: 10.1097/WAD.0b013e3180687418

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  18 in total

1.  Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.

Authors:  Géraldine Poisnel; Anne-Sophie Hérard; Nadine El Tannir El Tayara; Emmanuel Bourrin; Andreas Volk; Frank Kober; Benoit Delatour; Thierry Delzescaux; Thomas Debeir; Thomas Rooney; Jésus Benavides; Philippe Hantraye; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2011-11-12       Impact factor: 4.673

2.  BRANT: A Versatile and Extendable Resting-State fMRI Toolkit.

Authors:  Kaibin Xu; Yong Liu; Yafeng Zhan; Jiaji Ren; Tianzi Jiang
Journal:  Front Neuroinform       Date:  2018-09-03       Impact factor: 4.081

3.  Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.

Authors:  Ozioma C Okonkwo; Guofan Xu; Jennifer M Oh; N Maritza Dowling; Cynthia M Carlsson; Catherine L Gallagher; Alex C Birdsill; Matthew Palotti; Whitney Wharton; Bruce P Hermann; Asenath LaRue; Barbara B Bendlin; Howard A Rowley; Sanjay Asthana; Mark A Sager; Sterling C Johnson
Journal:  Cereb Cortex       Date:  2012-12-12       Impact factor: 5.357

Review 4.  Mapping Neurodegenerative Disease Onset and Progression.

Authors:  William W Seeley
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 5.  Brain imaging in the study of Alzheimer's disease.

Authors:  Eric M Reiman; William J Jagust
Journal:  Neuroimage       Date:  2011-12-07       Impact factor: 6.556

6.  Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.

Authors:  Xi-Chen Zhu; Hui-Fu Wang; Teng Jiang; Huan Lu; Meng-Shan Tan; Chen-Chen Tan; Lin Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 7.  Neuroimaging in dementia.

Authors:  Paolo Vitali; Raffaella Migliaccio; Federica Agosta; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2008-10-08       Impact factor: 3.420

8.  Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Jessica B S Langbaum; Kewei Chen; Wendy Lee; Cole Reschke; Dan Bandy; Adam S Fleisher; Gene E Alexander; Norman L Foster; Michael W Weiner; Robert A Koeppe; William J Jagust; Eric M Reiman
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

Review 9.  The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).

Authors:  C C Gispen-de Wied; M Kritsidima; A J A Elferink
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

10.  Impaired long distance functional connectivity and weighted network architecture in Alzheimer's disease.

Authors:  Yong Liu; Chunshui Yu; Xinqing Zhang; Jieqiong Liu; Yunyun Duan; Aaron F Alexander-Bloch; Bing Liu; Tianzi Jiang; Ed Bullmore
Journal:  Cereb Cortex       Date:  2013-01-11       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.